← Open Payments lookup

JAY GLADSTEIN: Open Payments

NPI 1154428613 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$125,046 in 235 payments from 23 companies in 2025. Trend: 2023 $116,446 · 2024 $143,424 · 2025 $125,046

Speaker / faculty: $89,085Consulting: $16,920Travel & lodging: $11,456Food & beverage: $7,585
CompanyPaymentsAmount
Gilead Sciences, Inc.84$73,283
ViiV Healthcare Company100$50,423
ABBVIE INC.11$312
Corium, LLC4$128
EMD Serono, Inc.3$116
Bausch Health US, LLC4$80
Antares Pharma, Inc.3$74
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$74
Merck Sharp & Dohme LLC3$71
Lilly USA, LLC3$68

Products named: CABENUVA, Biktarvy, Yeztugo, Descovy, DOVATO, APRETUDE, VRAYLAR, Azstarys.

Industry payments across CA — which companies pay providers there.